Navigation Links
Will Rogers Institute to Honor World's Leading Geneticist and Recent Medal of Freedom Recipient, Dr. Francis S. Collins For His Outstanding Contribution to Lung Research.
Date:11/27/2007

Resulting in the advancement of treatment Of Cystic Fibrosis

LOS ANGELES, Nov. 27 /PRNewswire/ -- It is impossible to over estimate the effect Dr. Francis S. Collins' work has had on public health. Fifty years ago, children living with cystic fibrosis (CF) would not have been expected to live past their early teens. Thanks to the research work of Dr. Collins, and the subsequent advancement in treatment, people can now expect to live into their thirties, forties and beyond.

It is in recognition of his extraordinary work on the CF gene and identification of the human genome, that the Will Rogers Institute (WRI) will honor Dr. Collins with the inaugural "Annual Prize for Outstanding Contributions to Lung Research." The award will be presented on Thursday, December 6, 2007 at the WRI Board of Directors Meeting at the Beverly Hills Hotel.

Dr. Collins' seminal research led to the identification of the CF gene and its protein product, CFTR. Mutation of the gene results in CF, a chronic disease which attacks the lungs and other organs. It is estimated that 30,000 children and adults in the United States struggle with cystic fibrosis. More than 10 million Americans are unknowing, symptom-free carriers of the disease, which can only be identified by genetic testing.

His work has proved to be a motivator for advancements in many other genetic investigations including type 2 diabetes, neurofibromatosis and Huntington's disease.

Dr. Edward Crandall, PhD, MD, medical advisor to the Will Rogers Institute and Hastings Professor and Norris Chair of Medicine at the University of Southern California (USC), stated, "Dr. Collins was chosen by the WRI as the first recipient of the prize because his work has consistently produced outstanding and influential research that has been published in the foremost peer-review journals. He maintains a very important leadership role in his field, and is held in the highest esteem by scientists and clinicians throughout the world."

As further testament to the importance of his work, on November 5, 2007 President George W. Bush presented Dr. Collins with the Medal of Freedom, one of the nation's highest civilian honors, for his contribution to genetic research. The Human Genome Project identified the genes in human DNA, stored the data and made it available for research. This project alone has revolutionized genetic research.

A native of the east coast, Dr. Collins studied chemistry at the University of Virginia (BS) and Yale University (PhD) and received his MD from the University of North Carolina. He undertook residency training in medicine at North Carolina before returning to Yale as a Fellow in Human Genetics from 1981 to 1984. Dr. Collins was appointed Director of the National Genome Research Institute of the National Institutes of Health in 1993.

Press Contact: Jane LaBonte (310) 801-3902


'/>"/>
SOURCE Will Rogers Institute
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. Award-winning QUITPLAN(R) Services Billboard Debuts in Rogers
2. RediClinic Adds Arkansas Blue Cross and Blue Shield Coverage in Fayetteville and Rogers
3. Health IT Now! Coalition Applauds Representatives Eshoo and Rogers for Introducing Health IT Legislation
4. Bryan R. Rogers Appointed President of Far West Division
5. National physician organization supports Capps-Rogers Bill at todays congressional briefing
6. Mayo Clinic Multidisciplinary Simulation Center Receives Distinction as an ACS-Accredited Education Institute
7. The Risk Management and Patient Safety Institute Announces Annual Health Care Risk Conference Dates
8. LifeNet Health Establishes The Skin & Wound Allograft Institute
9. Statement from Employment Policies Institute on Senator Hillary Clintons Health Care Plan
10. CAS Medical Systems, Inc. Awarded $2.8 Million Grant by National Institutes of Health
11. Portico Systems to Share Provider Network Management Best Practices at Institute for International Research
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2016)... ... June 25, 2016 , ... First Choice Emergency Room , ... Sesan Ogunleye, as the Medical Director of its new Mesquite-Samuell Farm facility. , ... our new Mesquite location,” said Dr. James M. Muzzarelli, Executive Medical Director of First ...
(Date:6/25/2016)... , ... June 25, 2016 , ... ... and non-athletes recover from injury. Recently, he has implemented orthobiologic procedures as a ... area —Johnson is one of the first doctors to perform the treatment. Orthobiologics ...
(Date:6/25/2016)... (PRWEB) , ... June 25, 2016 , ... Conventional wisdom ... of success. In terms of the latter, setting the bar too high can result ... more than just slow progress toward their goal. , Research from PsychTests.com ...
(Date:6/24/2016)... ... ... Those who have experienced traumatic events may suffer from a complex set of ... or alcohol abuse, as a coping mechanism. To avoid this pain and suffering, Serenity ... event. , Trauma sufferers tend to feel a range of emotions, from depression, guilt, ...
(Date:6/24/2016)... ... ... in a crisis. Her son James, eight, was out of control. Prone to extreme mood ... something upset him, he couldn’t control his emotions,” remembers Marcy. “If there was a ... children and say he was going to kill them. If we were driving on ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... , June 24, 2016 ... of the "Structural Electronics 2015-2025: Applications, Technologies, ... In-Mold Electronics, Smart Skin, ... Photovoltaics Structural electronics involves electronic ... load-bearing, protective structures, replacing dumb structures such as ...
(Date:6/24/2016)... Calif. , June 24, 2016  American Respiratory Labs (ARL), ... is now able to perform sophisticated lung assessments in patients, homes, ... , Inc. Patients are no longer limited to ... EasyOne PRO ® , ARL patients like Jeanne R. of ... in the comfort of her own home. ...
(Date:6/24/2016)... LEXINGTON, Mass. , June 24, 2016   ... specialty pharmaceutical company developing innovative inhaled drugs, announced today ... when Russell Investments reconstituted its comprehensive set ... 2016. "This is an important milestone for ... "It will increase shareholder awareness of our progress in ...
Breaking Medicine Technology: